Opioid drugs are prescribed to relieve severe pain and are highly addictive. Some key products include oxycodone, hydrocodone, codeine, morphine etc. .
British drugmaker GSK on Monday said the human medicines committee of the European Medicines Agency had recommended approving its oral therapy to treat anaemia in patients with a type of bone marrow cancer called myelofibrosis. A decision for the marketing authorization of the therapy, momelotinib, is expected by early 2024, GSK said in a statement.
Jayme Heim, MSN, FNP-BC; and Lauren Miller, MPAS, PA-C, share thoughts on the use of oral systemic and biologic treatments in plaque psoriasis, commenting on the need for personalized care for patients.
The approval comes after the health regulator in July delayed its decision to review additional data. The therapy, momelotinib, has been approved for patients who were previously treated using an FDA-approved, anti-inflammatory class of drugs called JAK inhibitors. Myelofibrosis is associated with high levels of hepcidin and disrupts the body's production of blood cells, often causing severe anemia, or a deficiency of red blood cells.